首页|化橘红配方颗粒通过维持铁稳态并抑制脂质过氧化和铁死亡缓解斑马鱼脂肪性肝病

化橘红配方颗粒通过维持铁稳态并抑制脂质过氧化和铁死亡缓解斑马鱼脂肪性肝病

扫码查看
目的 探讨化橘红配方颗粒治疗脂肪性肝病(FLD)的药效作用和具体机制。方法 将受精后3d的斑马鱼幼鱼随机分为空白组、模型对照组、化橘红配方颗粒处理组(16、32、64μg/mL),分别构建斑马鱼幼鱼非酒精性脂肪肝(NAFLD)和酒精性脂肪肝(ALD)模型,采用生存分析、病理组织切片、全鱼油红O染色和实时定量荧光PCR实验评价化橘红配方颗粒治疗FLD的药效,并从CAV1和铁代谢及铁死亡角度探讨其治疗FLD的具体机制,通过普鲁士蓝染色、DCFH-DA活体探针、丙二醛含量检测、实时定量荧光PCR实验和CAV1免疫组织化学染色分析化橘红配方颗粒治疗FLD的药效验证和具体机制。结果 化橘红配方颗粒能减轻斑马鱼幼鱼NAFLD和ALD模型中的脂质累积,减少脂肪酸合成酶、固醇调节元件结合蛋白1、3-羟基-3-甲基戊二酰辅酶A还原酶、肿瘤坏死因子-α和白介素6的表达水平,升高载脂蛋白A1和PPARα表达水平。化橘红配方颗粒可以减少斑马鱼幼鱼NAFLD和ALD模型中肝脏的铁沉积,减少幼鱼体内的丙二醛和活性氧含量(P<0。05)。NAFLD状态下,不同浓度的化橘红配方颗粒可升高Tf、TfR、FPN和SLC7A11表达(P<0。05),中、高浓度的化橘红配方颗粒可升高谷胱甘肽过氧化物酶4(GPX4)的表达(P<0。05);ALD状态下,斑马鱼幼鱼的Tf、TfR和FPN表达升高,不同浓度的化橘红配方颗粒可降低这些基因的表达(P<0。05)。化橘红配方颗粒对ALD状态下SLC7A11的表达无明显影响,但高浓度的化橘红配方颗粒可升高GPX4的表达(P<0。05),免疫组织化学染色和实时定量荧光PCR实验结果显示,在NAFLD和ALD状态下,斑马鱼幼鱼肝脏的CAV1升高,而中、高浓度的化橘红配方颗粒可明显改善评价两种脂肪肝状态下斑马鱼幼鱼肝脏的CAV1表达。结论 化橘红配方颗粒可减轻NAFLD和ALD的脂质累积和炎症反应,并通过减少CAV1的表达纠正NAFLD和ALD的铁稳态失衡、脂质过氧化和铁死亡。
Exocarpium Citri Grandis formula granules alleviate fatty liver disease in Zebrafish by maintaining iron homeostasis and suppressing lipid peroxidation and ferroptosis
Objective To investigate the therapeutic effect of Exocarpium Citri Grandis formula granules(ECGFG)on fatty liver disease(FLD)in zebrafish and explore the underlying mechanism.Methods Nonalcoholic fatty liver disease(NAFLD)and alcoholic fatty liver disease(ALD)models were established in zebrafish larvae at 3 days post fertilization(dpf),in which the treatment efficacy of 16,32,or 64 μg/mL ECGFG was evaluated by examining zebrafish survival and liver pathologies and using whole-fish oil red O staining and RT-qPCR.The therapeutic mechanism of ECGFG for FLD was investigated using Prussian blue staining,DCFH-DA probe,MDA content detection,RT-qPCR assay and immunohistochemical staining for CAV1.Results In zebrafish models of NAFLD and ALD,treatment with ECGFG significantly reduced lipid accumulation and the expression levels of FASN,SREBP1,HMGCRA,TNF-α and IL-6,increased the expressions of Apoa1 and PPARα,and reduced iron deposition and the contents of MDA and ROS in the liver.In zebrafish models of NAFLD,treatment with ECGFG at the 3 doses significantly increased hepatic expressions of Tf,TfR,FPN and SLC7A11,and at the doses of 32 and 64 μg/mL,ECGFG obviously increased hepatic expression of GPX4.ALD fish models showed significantly increased hepatic expressions of Tf,TfR and FPN,which were effectively lowered by treatment with ECGFG at the 3 doses.ECGFG did not obviously affect the expression of SLC7A11,but its high dose(64 μg/mL)caused significant elevation of GPX4 expression.Both zebrafish models of NAFLD and ALD showed obviously increased CAV1 expression level in the liver,which was significantly reduced by treatment with 32 and 64 μg/mL ECGFG.Conclusion In zebrafish models of NAFLD and ALD,ECGFG can alleviate lipid accumulation and inflammatory response and lower the expression level of CAV1 to restore iron homeostasis and suppress lipid peroxidation and ferroptosis in the liver.

fatty liver diseaseExocarpium Citri Grandisformula granuleszebrafishiron homeostasis

张榆雪、蓝洁莹、马昕怡、周琼、秦梦晨、高磊

展开 >

南方医科大学中医药学院,广东 广州 510515

南方医科大学第一临床医学院,广东 广州 510515

广东省中药制剂重点实验室,广东 广州 510515

广东省中西医结合防治情志病基础研究卓越中心,广东 广州 510515

展开 >

脂肪性肝病 化橘红 配方颗粒 斑马鱼 铁死亡

2024

南方医科大学学报
南方医科大学

南方医科大学学报

CSTPCD北大核心
影响因子:1.654
ISSN:1673-4254
年,卷(期):2024.44(12)